Charles River Laboratories Interna
$290.19Change from previous close: +1.17%Absolute change: +$3.36
At a glance
- Revenue growth
- −0.85%
- 2025 vs 2024
- Net margin
- -3.6%
- 2024: 0.3%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total revenue | 1,004 | 996 | 994 | 1,005 | 1,032 |
| Cost of revenue | 641 | 701 | 685 | 666 | 675 |
| Gross profit | 363 | 295 | 310 | 339 | 357 |
| Selling, general and administrative | 229 | 159 | 196 | 178 | 192 |
| Operating income | 120 | 120 | 92.5 | 134 | 100 |
| EBIT | 83.5 | -3.2 | -270 | 113 | 101 |
| EBITDA | 151 | 64.0 | -192 | 198 | 221 |
| Interest expense | 30.3 | 26.7 | 23.8 | 25.4 | 30.0 |
| Pre-tax income | 53.2 | -29.9 | -294 | 87.2 | 71.4 |
| Income tax | 53.9 | -15.1 | -17.8 | 31.6 | 18.7 |
| Net income | -1.5 | -14.8 | -277 | 54.4 | 52.3 |
| Net income to common shareholders | -1.5 | -14.8 | -277 | 54.4 | 52.3 |
| Basic EPS | -0.03 | -0.30 | -5.62 | 1.11 | 1.06 |
| Diluted EPS | -0.03 | -0.30 | -5.62 | 1.10 | 1.06 |
| Average shares (basic) | 48.0 | 49.0 | 49.2 | 49.2 | 49.1 |
| Average shares (diluted) | 48.0 | 49.0 | 49.2 | 49.4 | 49.3 |